Patents Assigned to TED'S BRAIN SCIENCE, INC.
  • Patent number: 11103465
    Abstract: The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: August 31, 2021
    Assignee: Ted's Brain Science, Inc.
    Inventors: Dennis I. Robbins, David H. Hitt, Jr., David H. Hitt, III
  • Publication number: 20210046018
    Abstract: The present disclosure provides ophthalmic compositions containing resveratrol. Also provided are methods of using ophthalmic resveratrol compositions to treat acute ocular pain, chronic ocular pain, dry eye disease, and/or photophobia.
    Type: Application
    Filed: August 13, 2020
    Publication date: February 18, 2021
    Applicants: TED'S BRAIN SCIENCE, INC., BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, OREGON HEALTH AND SCIENCE UNIVERSITY
    Inventors: SUE A. AICHER, GREGORY O. DUSSOR, THEODORE J. PRICE, DENNIS I. ROBBINS, DAVID H. HITT, II, DAVID H. HITT, III